Literature DB >> 18508168

Reductions in the tobacco specific nitrosamine (TSNA) content of tobaccos taken from commercial Canadian cigarettes and corresponding reductions in TSNA deliveries in mainstream smoke from such cigarettes.

W S Rickert1, P J Joza, M Sharifi, J Wu, J H Lauterbach.   

Abstract

Tobacco specific nitrosamines (TSNAs) are suspected to cause smoking-related neoplastic diseases. The change from direct-fired to indirect-fired barns (aka kilns) for curing bright (aka Virginia, flue-cured) tobaccos was made to reduce the TSNA concentrations. The effectiveness of such processes in reducing the deliveries of TSNAs to the users of the products should be monitored. However, it is difficult to assess the effects of this reduction on the TSNA levels in mainstream smoke when cigarette blends contain burley tobaccos and other blend components that can increase smoke TSNA concentrations. Canadian cigarettes made prior to and in the few years just after the conversion to indirect-fired curing should not be subject to such interferences. Thus, the TSNA content of tobaccos and mainstream smoke from six brands of Canadian cigarettes produced in 2003, 2004, and 2005 were determined. Reductions in NNK [4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone], the most important TSNA in flue-cured tobaccos, levels in the tobacco blends ranged from 60% to 85%. The corresponding reductions in mainstream smoke TSNA levels ranged from 59% to 72% (ISO smoking conditions) and 58-76% (Health Canada Intensive smoking conditions). These results show that other factors (microorganisms, nitrite levels) may be negating the TSNA reductions achieved by indirect-fired curing.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508168     DOI: 10.1016/j.yrtph.2008.04.009

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  7 in total

1.  Effect of differing levels of tobacco-specific nitrosamines in cigarette smoke on the levels of biomarkers in smokers.

Authors:  David L Ashley; Richard J O'Connor; John T Bernert; Clifford H Watson; Gregory M Polzin; Ram B Jain; David Hammond; Dorothy K Hatsukami; Gary A Giovino; K Michael Cummings; Ann McNeill; Lion Shahab; Bill King; Geoffrey T Fong; Liqin Zhang; Yang Xia; Xizheng Yan; Joan M McCraw
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

2.  Carcinogenic tobacco-specific N-nitrosamines in US cigarettes: three decades of remarkable neglect by the tobacco industry.

Authors:  Irina Stepanov; Aleksandar Knezevich; Liqin Zhang; Clifford H Watson; Dorothy K Hatsukami; Stephen S Hecht
Journal:  Tob Control       Date:  2011-05-20       Impact factor: 7.552

3.  Trends Over Time in Tobacco-Specific Nitrosamines (TSNAs) in Whole Tobacco and Smoke Emissions From Cigarettes Sold in Canada.

Authors:  Christine D Czoli; David Hammond
Journal:  Nicotine Tob Res       Date:  2018-04-02       Impact factor: 4.244

4.  Role of l- and d-Menthol in the Glucuronidation and Detoxification of the Major Lung Carcinogen, NNAL.

Authors:  Shannon Kozlovich; Gang Chen; Christy J W Watson; William J Blot; Philip Lazarus
Journal:  Drug Metab Dispos       Date:  2019-10-02       Impact factor: 3.922

Review 5.  Cigarette Filter Ventilation and its Relationship to Increasing Rates of Lung Adenocarcinoma.

Authors:  Min-Ae Song; Neal L Benowitz; Micah Berman; Theodore M Brasky; K Michael Cummings; Dorothy K Hatsukami; Catalin Marian; Richard O'Connor; Vaughan W Rees; Casper Woroszylo; Peter G Shields
Journal:  J Natl Cancer Inst       Date:  2017-12-01       Impact factor: 13.506

Review 6.  Surveillance methods for identifying, characterizing, and monitoring tobacco products: potential reduced exposure products as an example.

Authors:  Richard J O'Connor; K Michael Cummings; Vaughan W Rees; Gregory N Connolly; Kaila J Norton; David Sweanor; Mark Parascandola; Dorothy K Hatsukami; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

7.  Influence of microbiota and metabolites on the quality of tobacco during fermentation.

Authors:  Jingjing Li; Yuanyuan Zhao; Yanqing Qin; Hongzhi Shi
Journal:  BMC Microbiol       Date:  2020-11-19       Impact factor: 3.605

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.